Table 2 Patient characteristics of study population at individual WANETAM study sites
| Â | Burkina Faso | The Gambia | Ghana | Guinea-Bissau | Mali | Nigeria Ibadan | Nigeria Lagos | Senegal | Togo | All study sites | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | ||
Total | 27 | (3) | 104 | (11) | 127 | (13) | 44 | (5) | 208 | (21) | 57 | (6) | 120 | (12) | 75 | (8) | 212 | (21) | 974 | (100) | |
Treatment history | New | 20 | (74) | 9 | (9) | 15 | (12) | 32 | (73) | 150 | (72) | 13 | (23) | 28 | (23) | 55 | (73) | 94 | (44) | 416 | (43) |
Retreatment | 1 | (4) | 95 | (91) | 112 | (88) | 4 | (9) | 58 | (28) | 44 | (77) | 88 | (73) | 20 | (27) | 112 | (53) | 534 | (55) | |
Unknown | 6 | (22) | 0 | (0) | 0 | (0) | 8 | (18) | 0 | (0) | 0 | (0) | 4 | (3) | 0 | (0) | 6 | (3) | 24 | (2) | |
Age | 0–14 | 0 | (0) | 0 | (0) | 1 | (1) | 1 | (3) | 4 | (2) | 3 | (5) | 1 | (1) | 4 | (5) | 3 | (1) | 17 | (2) |
15–24 | 3 | (14) | 31 | (30) | 16 | (13) | 10 | (26) | 50 | (24) | 6 | (10) | 16 | (14) | 12 | (16) | 27 | (13) | 171 | (18) | |
25–34 | 3 | (14) | 31 | (30) | 35 | (29) | 12 | (31) | 78 | (38) | 21 | (37) | 45 | (39) | 25 | (34) | 57 | (27) | 307 | (31) | |
35–44 | 8 | (38) | 20 | (20) | 32 | (26) | 7 | (18) | 38 | (18) | 15 | (26) | 32 | (28) | 14 | (19) | 57 | (27) | 223 | (23) | |
45–54 | 3 | (14) | 10 | (10) | 26 | (21) | 6 | (15) | 21 | (10) | 8 | (14) | 12 | (10) | 7 | (9) | 42 | (20) | 135 | (14) | |
55–64 | 2 | (10) | 7 | (7) | 4 | (3) | 1 | (3) | 11 | (5) | 2 | (4) | 9 | (8) | 5 | (7) | 13 | (6) | 54 | (5) | |
65+ | 2 | (10) | 3 | (3) | 8 | (7) | 2 | (5) | 6 | (3) | 2 | (4) | 1 | (1) | 7 | (9) | 9 | (4) | 40 | (4) | |
Unknown | 6 | – | 2 | - | 5 | - | 5 | – | 0 | – | 0 | – | 4 | – | 1 | – | 4 | – | 27 | (3) | |
Sex | Female | 7 | (33) | 31 | (30) | 29 | (24) | 18 | (44) | 51 | (25) | 23 | (40) | 54 | (46) | 17 | (23) | 76 | (36) | 306 | (31) |
Male | 14 | (67) | 73 | (70) | 93 | (76) | 23 | (56) | 157 | (75) | 34 | (60) | 63 | (54) | 58 | (77) | 136 | (64) | 650 | (67) | |
Unknown | 6 | – | 0 | - | 5 | - | 3 | – | 0 | – | 0 | – | 3 | – | 0 | – | 1 | – | 18 | (2) | |
HIV | Negative | 0 | (0) | 56 | (54) | 25 | (20) | 0 | (0) | 172 | (83) | 42 | (74) | 46 | (38) | 15 | (20) | 115 | (54) | 471 | (48) |
Positive | 0 | (0) | 5 | (5) | 3 | (2) | 12 | (27) | 29 | (14) | 4 | (7) | 27 | (23) | 12 | (16) | 36 | (17) | 128 | (14) | |
Unknown | 27 | (100) | 43 | (41) | 99 | (78) | 32 | (73) | 7 | (3) | 11 | (19) | 47 | (39) | 48 | (64) | 61 | (29) | 375 | (38) | |